EW Share Price Performance
US$89.83
8.67 (10.68%)
11.0% undervalued intrinsic discount
US$100.96
Fair Value
Price US$89.83
AnalystConsensusTarget US$100.96
Fair ValueUS$100.96
Share Pricen/a
Seeking Alpha • Aug 12
Edwards Lifesciences Corporation Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 72 Fair Values set on narratives written by author
EW Community Narratives
AN
Fair Value
·Fair Value US$100.96 11.0% undervalued intrinsic discount
Durability Data And Real-World Evidence Will Shape Risk And Opportunity Ahead
0users have liked this narrative
0users have commented on this narrative
27users have followed this narrative
Durability Data And Real-World Evidence Will Shape Risk And Opportunity Ahead
Edwards Lifesciences is lining up new heart valve treatments that could open the door to more patients and help it grow in areas where it already has strong momentum. But trade rules, tough competition overseas, and the cost of new deals and research could squeeze profits if the rollout takes longer than expected.Read more
AN
US$100.96
11.0% undervalued intrinsic discount
Fair Value
Revenue
9.32% p.a.
Profit Margin
26.17%
Future PE
30.61x
Price in 2029
US$124.93
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
EW: CMS TAVR Policy Shift Will Extend Structural Heart Upside
Fair Value: US$100.96 11.0% undervalued intrinsic discount
27 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Edwards Lifesciences Corporation Key Details
About EW
- Founded
- 1958
- Employees
- 16000
- CEO
- WebsiteView website
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Recent EW News & Updates
Narrative Update • Jul 30
